Teva Pharmaceutical Industries Ltd (NYSE:TEVA) stock is trading higher on Wednesday after the company’s first-quarter 2025 financial results. Here are the details. Teva reported revenue of $3.89 ...
Teva Pharmaceutical is one of the world's largest generic drug companies. Teva is working to differentiate itself in generics by focusing on harder-to-produce drugs. Teva has begun manufacturing its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback